CHESS ROBERT 4
4 · NEKTAR THERAPEUTICS · Filed Jun 14, 2024
Insider Transaction Report
Form 4
CHESS ROBERT
Director
Transactions
- Sale
Common Stock
2024-06-14$1.20/sh−19,500$23,400→ 255,273 total
Holdings
- 2,100(indirect: by daughter)
Common Stock
- 2,100(indirect: by daughter)
Common Stock
- 2,100(indirect: by son)
Common Stock
Footnotes (3)
- [F1]This transaction was made pursuant to a Rule 10b5-1 trading plan.
- [F2]This transaction was executed in multiple trades at prices ranging from $1.19 to $1.23. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon the request to the SEC staff, the Issuer, or a security holder of the Issuer.
- [F3]The reporting person disclaims beneficial ownership of these shares, and this report shall not be deemed an admission that the reporting person is the beneficial owner of these shares for the purposes of Section 16 or for any other purpose.